Reference
Institute for Clinical and Economic Review. ICER to Assess Treatment for Hypertrophic Cardiomyopathy Internet Document : 8 Apr 2021. Available from: URL: https://icer.org/news-insights/press-releases/icer-to-assess-treatment-for-hypertrophic-cardiomyopathy/
Rights and permissions
About this article
Cite this article
ICER assessing mavacamten for hypertrophic cardiomyopathy. PharmacoEcon Outcomes News 877, 30 (2021). https://doi.org/10.1007/s40274-021-7679-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-021-7679-y